GABAPENTIN | A207099 | RISING PHARMA HOLDINGS INC
Highest NADAC/Unit
$0.0428
per ea
Lowest NADAC/Unit
$0.0219
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571086950GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 16571086901GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 16571086910GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 16571086810GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 16571086801GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 16571086850GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.